Linezolid
Brand names: Zyvox
Linezolid is an oxazolidinone antibacterial active against Gram-positive organisms, including MRSA and vancomycin-resistant enterococci, used for pneumonia and complicated skin and soft-tissue infections.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds the 23S ribosomal RNA of the 50S subunit, preventing formation of the functional 70S initiation complex and thereby inhibiting bacterial protein synthesis.
Prescribing in practice
- It is a reversible, non-selective monoamine oxidase inhibitor and can precipitate serotonin syndrome with serotonergic drugs such as SSRIs, so combinations must be reviewed and tyramine-rich foods limited.
- Reversible myelosuppression, particularly thrombocytopenia, can occur, with greater risk when courses are prolonged.
- Prolonged use beyond the usual duration risks optic and peripheral neuropathy and lactic acidosis, so treatment is generally time-limited.
Monitoring
Monitor full blood count weekly, especially with longer courses, and review for visual symptoms, peripheral neuropathy and signs of serotonin syndrome.
Counselling the patient
- Report any changes in vision, numbness or tingling in the hands or feet promptly.
- Avoid large amounts of tyramine-rich foods such as mature cheese and yeast extracts.
- Tell your team about antidepressants or other medicines that affect serotonin.
Evidence & guidelines
Prescribing reflects the SPC and MHRA advice on monitoring for blood disorders, optic neuropathy and serotonin syndrome.
Reference: NICE CKS; UK AMR guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023